Bellevue Healthcare (BBH) Competitors GBX 119.40 -2.00 (-1.65%) As of 07/11/2025 12:29 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock BBH vs. HRI, EDIN, ASHM, IHP, TRY, GSS, JFJ, AGT, BPCR, and BRWMShould you be buying Bellevue Healthcare stock or one of its competitors? The main competitors of Bellevue Healthcare include Herald (HRI), Edinburgh Investment (EDIN), Ashmore Group (ASHM), IntegraFin (IHP), TR Property Investment Trust (TRY), Genesis Emerging Markets Fund (GSS), JPMorgan Japanese (JFJ), AVI Global Trust (AGT), BioPharma Credit (BPCR), and BlackRock World Mining Trust (BRWM). These companies are all part of the "asset management" industry. Bellevue Healthcare vs. Its Competitors Herald Edinburgh Investment Ashmore Group IntegraFin TR Property Investment Trust Genesis Emerging Markets Fund JPMorgan Japanese AVI Global Trust BioPharma Credit BlackRock World Mining Trust Herald (LON:HRI) and Bellevue Healthcare (LON:BBH) are both small-cap asset management industry companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability. Do institutionals and insiders have more ownership in HRI or BBH? 31.8% of Herald shares are owned by institutional investors. Comparatively, 40.6% of Bellevue Healthcare shares are owned by institutional investors. 5.4% of Herald shares are owned by insiders. Comparatively, 0.1% of Bellevue Healthcare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media prefer HRI or BBH? In the previous week, Herald had 1 more articles in the media than Bellevue Healthcare. MarketBeat recorded 1 mentions for Herald and 0 mentions for Bellevue Healthcare. Herald's average media sentiment score of 0.61 beat Bellevue Healthcare's score of 0.00 indicating that Herald is being referred to more favorably in the media. Company Overall Sentiment Herald Positive Bellevue Healthcare Neutral Which has better earnings and valuation, HRI or BBH? Herald has higher revenue and earnings than Bellevue Healthcare. Bellevue Healthcare is trading at a lower price-to-earnings ratio than Herald, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHerald£162.63M7.27£175.20M£346.546.77Bellevue Healthcare-£9.60M-30.67-£16.23M-£6.57-18.16 Is HRI or BBH more profitable? Bellevue Healthcare has a net margin of 169.10% compared to Herald's net margin of 107.72%. Herald's return on equity of 14.78% beat Bellevue Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Herald107.72% 14.78% 9.22% Bellevue Healthcare 169.10%-4.48%N/A SummaryHerald beats Bellevue Healthcare on 10 of the 12 factors compared between the two stocks. Get Bellevue Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BBH vs. The Competition Export to ExcelMetricBellevue HealthcareAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£294.27M£1.25B£6.16B£3.00BDividend Yield3.82%4.39%4.21%5.02%P/E Ratio-18.1622.1013.27150.83Price / Sales-30.672,368.081,738.23314,599.95Price / CashN/A60.81128.1027.97Price / Book0.801.221.914.58Net Income-£16.23M£263.98M£1.23B£5.90B7 Day Performance0.34%14.37%11.18%11.51%1 Month Performance-3.55%3.20%7.30%8.27%1 Year Performance-18.11%5.55%17.74%32.75% Bellevue Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BBHBellevue HealthcareN/AGBX 119.40-1.6%N/A-18.1%£294.27M-£9.60M-18.16N/AHRIHeraldN/AGBX 2,313.53+0.8%N/A+3.3%£1.17B£162.63M6.686,600Negative NewsEDINEdinburgh InvestmentN/AGBX 797.25+0.5%N/A+6.4%£1.15B£189.32M6.38N/AASHMAshmore Group0.7631 of 5 starsGBX 161.60+2.9%GBX 174+7.7%-6.8%£1.08B£199.65M11.45283News CoverageAnalyst ForecastGap UpIHPIntegraFinN/AGBX 323.75+2.0%GBX 406.67+25.6%-11.7%£1.08B£138.65M20.533,520Positive NewsDividend IncreaseTRYTR Property Investment TrustN/AGBX 333.15+0.5%N/A-3.1%£1.06B£311.14M3.7326GSSGenesis Emerging Markets FundN/AN/AN/AN/A£1.06B£250.40M6.181,626Gap DownJFJJPMorgan JapaneseN/AGBX 642.66-0.1%N/A+12.0%£1.06B£198.16M5.43N/AAGTAVI Global TrustN/AGBX 242.19+0.1%N/A+1.0%£1.05B£219.59M4.86N/APositive NewsBPCRBioPharma CreditN/AGBX 0.88+0.2%N/A+0.5%£1.05B£12.99B10.03N/AHigh Trading VolumeBRWMBlackRock World Mining TrustN/AGBX 545.58+0.3%N/A-5.0%£1.04B£8.73M-78.05147,000 Related Companies and Tools Related Companies Herald Alternatives Edinburgh Investment Alternatives Ashmore Group Alternatives IntegraFin Alternatives TR Property Investment Trust Alternatives Genesis Emerging Markets Fund Alternatives JPMorgan Japanese Alternatives AVI Global Trust Alternatives BioPharma Credit Alternatives BlackRock World Mining Trust Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:BBH) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bellevue Healthcare Please log in to your account or sign up in order to add this asset to your watchlist. Share Bellevue Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.